Anticancer vitamins du jour - The ABCED's so far

American Journal of Epidemiology

Volumn 172, Issue 1, 2010, Pages 1-3

  Byers, Tim ^a  

^a Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; VITAMIN; ALPHA TOCOPHEROL; ASCORBIC ACID; FOLIC ACID; RETINOL; RIBOFLAVIN; VITAMIN D;

BODY MASS; CANCER INCIDENCE; CANCER RISK; CIRCULATION; DIGESTIVE SYSTEM CANCER; EDITORIAL; ENDOMETRIUM CANCER; KIDNEY CANCER; NONHODGKIN LYMPHOMA; NUTRITION; PANCREAS CANCER; PHYSICAL ACTIVITY; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; ANIMAL; CHEMICALLY INDUCED DISORDER; HUMAN; NEOPLASM; NOTE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; ASCORBIC ACID; FOLIC ACID; HUMANS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIBOFLAVIN; VITAMIN A; VITAMIN D; VITAMIN E; VITAMINS;

EID: 77958069784     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq112     Document Type: Editorial

References (23)

1. Peto R, Doll R, Buckley JD, et al. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981; 290(5803):201-208.
2. Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 1995;62(6 suppl):1427S- 1430S.
3. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18): 1150-1155.
4. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993; 85(18):1483-1492.
5. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297(21):2351-2359.
6. Ziegler RG, Byers T. Re: Health claims about vitamin C and cancer. J Natl Cancer Inst. 1994;86(11):871-872.
7. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328(20):1444-1449.
8. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328(20):1450-1456.
9. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):154-160.
10. Miller ER III, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase allcause mortality. Ann Intern Med. 2005;142(1):37-46.
11. Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA. 2003; 290(4):476-485.
12. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39-51.
13. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR; 2007.
14. IARC. Vitamin D and Cancer. IARC Working Group Reports, vol 5. Lyon, France: International Agency for Research on Cancer; 2008. http://www.iarc.fr/ en/publications/pdfs-online/wrk/wrk5/Report-VitD.pdf).
15. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19(7): 468-483.
16. Grant WB. A critical review of vitamin D and cancer: a report of the IARC Working Group. Dermatoendocrinol. 2009;1(1): 25-33.
17. McCullough ML, Stevens VL, Patel R, et al. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort [published online ahead of print August 28, 2009]. Breast Cancer Res. (doi:10.1186/ bcr2356).
18. Freedman DM, Chang SC, Falk RT, et al. Serum levels of vitamin D metabolites and breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev. 2008;17(4): 889-894.
19. Oh EY, Ansell C, Nawaz H, et al. Global breast cancer seasonality [published online ahead of print February 4, 2010]. Breast Cancer Res Treat. (doi:10.1007/s10549-0090676-7).
20. Helzlsouer KJ for the VDPP Steering Committee. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):4-9.
21. Goodwin PJ. Vitamin D in cancer patients: above all, do no harm. J Clin Oncol. 2009;27(13):2117-2119.
22. Olsen A, Egeberg R, Tjønneland A. Re: Calcium plus vitamin D supplementation and the risk of breast cancer [letter]. J Natl Cancer Inst. 2009;101(9):690.
23. Nass S, Stillman B, eds. Large-Scale Biomedical Science: Exploring Strategies for Future Research. Washington, DC: National Cancer Policy Board and Division of Earth and Life Sciences, Institute of Medicine, National Research Council; 2003.